We then focused on RFC2 as the most promising DDR-related biomarker because mRNA expression level of RFC2 is upregulated in CRPC tissue compared with Pca, as validated by qRT-PCR analysis. The gene discussed is RFC2; the disease is posterior cortical atrophy.